We are live on
!
Find out more
DHFB
Dixon Hubard Feinour & Brown Portfolio holdings
AUM
$842M
1-Year Est. Return
2.74%
This Fund
S&P 500
This Quarter
Est. Return
+10.09%
1 Year Est. Return
-2.74%
3 Year Est. Return
+59.78%
5 Year Est. Return
+118.87%
10 Year Est. Return
–
AUM
$390M
AUM Growth
+$4.4M
(+1.1%)
Cap. Flow
-$11.6M
Cap. Flow
% of AUM
-2.97%
Top 10 Holdings %
Top 10 Hldgs %
36.69%
Holding
189
New
3
Increased
22
Reduced
93
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$8.09M |
| 2 |
Qorvo
QRVO
|
+$3.18M |
| 3 |
DexCom
DXCM
|
+$296K |
| 4 |
Atlassian
TEAM
|
+$225K |
| 5 |
Qualys
QLYS
|
+$221K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$9.79M |
| 2 |
Centene
CNC
|
+$1.4M |
| 3 |
Apple
AAPL
|
+$1.26M |
| 4 |
Amazon
AMZN
|
+$757K |
| 5 |
lululemon athletica
LULU
|
+$746K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.4% |
| 2 | Technology | 24.34% |
| 3 | Consumer Discretionary | 11.23% |
| 4 | Communication Services | 8.9% |
| 5 | Consumer Staples | 7.76% |
Similar funds
BDWM
MCM
TFM
MWM
CP
BWM
FPS
IC
Dixon Hubard Feinour & Brown's Q3 2020 Portfolio in Review
As of Q3 2020, Dixon Hubard Feinour & Brown held 189 positions worth $390M, up 1.1% from $385M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Dixon Hubard Feinour & Brown's Q3 2020 filing shows 3 new, 22 increased, 93 reduced and 8 closed positions. Its largest new stake was Qorvo: 25,635 shares worth $3.31M. The largest sale was Edwards Lifesciences, an estimated $9.79M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Discretionary.
- Dixon Hubard Feinour & Brown's largest Q3 2020 buy was Qorvo: 25,635 shares worth $3.31M.
- Dixon Hubard Feinour & Brown added most to UnitedHealth in Q3 2020, an estimated $8.09M increase.
- Dixon Hubard Feinour & Brown's biggest Q3 2020 reduction was Apple, cutting an estimated $1.26M.
- Dixon Hubard Feinour & Brown fully exited Edwards Lifesciences in Q3 2020, selling an estimated $9.79M.
- Dixon Hubard Feinour & Brown's ten largest holdings make up 37% of its $390M portfolio in Q3 2020.
- Dixon Hubard Feinour & Brown opened 3 new positions and closed 8 in Q3 2020.
- Dixon Hubard Feinour & Brown's portfolio value rose 1.1% quarter-over-quarter to $390M.
Based on Dixon Hubard Feinour & Brown's 13F filing for Q3 2020, filed 12 Nov 2020.